P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT. (23rd June 2022) - Wahlin, B. E.; Brody, J.; Phillips, T.; Costello, R.; Lugtenburg, P.; Cordoba, R.; Wang, L.; Wu, J.; Elliott, B.; Abbas, A.; Jørgensen, J.